Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: A substudy of the belles trial (beyond endorsed lipid lowering with ebt scanning)

Journal of the American College of Cardiology

Volumn 61, Issue 19, 2013, Pages 1956-1961

  Alexopoulos, Nikolaos ^a   Melek, Bekir H ^a   Arepalli, Chesnal D ^a   Hartlage, Gregory Randell ^a   Chen, Zhengjia ^b   Kim, Sungjin ^b   Stillman, Arthur E ^a   Raggi, Paolo ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

atherosclerosis; epicardial adipose tissue; statins

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIAC COMPUTED TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EPICARDIAL ADIPOSE TISSUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; INTENSIVE LIPID LOWERING THERAPY; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MODERATE LIPID LOWERING THERAPY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MIDDLE AGED; POSTMENOPAUSE; PRAVASTATIN; PYRROLES; VASCULAR CALCIFICATION;

EID: 84875458263     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.051     Document Type: Article

References (36)

1. G. Iacobellis, A.M. Sharma Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome Curr Pharm Des 13 2007 2180 2184
2. D.S. McLean, A.E. Stillman Epicardial adipose tissue as a cardiovascular risk marker Clin Lipidol 4 2009 55 62
3. N. Alexopoulos, D.S. McLean, M. Janik, C.D. Arepalli, A.E. Stillman, P. Raggi Epicardial adipose tissue and coronary artery plaque characteristics Atherosclerosis 210 2010 150 154
4. T. Oka, H. Yamamoto, N. Ohashi Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography Int J Cardiol 161 2012 45 49
5. C.L. Schlett, M. Ferencik, M.F. Kriegel Association of pericardial fat and coronary high-risk lesions as determined by cardiac CT Atherosclerosis 222 2012 129 134
6. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
7. P. Raggi, M. Davidson, T.Q. Callister Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) Circulation 112 2005 563 571
8. T.Q. Callister, B. Cooil, S.P. Raya, N.J. Lippolis, D.J. Russo, P. Raggi Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method Radiology 208 1998 807 814
9. A. Lipson, N. Alexopoulos, G.R. Hartlage Epicardial adipose tissue is increased in patients with systemic lupus erythematosus Atherosclerosis 223 2012 389 393
10. R. Nakazato, R. Rajani, V.Y. Cheng Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography Atherosclerosis 220 2012 139 144
11. R. Taguchi, J. Takasu, Y. Itani Pericardial fat accumulation in men as a risk factor for coronary artery disease Atherosclerosis 157 2001 203 209
12. J. Ding, F.C. Hsu, T.B. Harris The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA) Am J Clin Nutr 90 2009 499 504
13. G. Iacobellis, M.C. Ribaudo, F. Assael Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk J Clin Endocrinol Metab 88 2003 5163 5168
14. A.R. Baker, N.F. Silva, D.W. Quinn Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease Cardiovasc Diabetol 5 2006 1
15. K. Harada, T. Amano, T. Uetani Cardiac 64-multislice computed tomography reveals increased epicardial fat volume in patients with acute coronary syndrome Am J Cardiol 108 2011 1119 1123
16. P. Schoenhagen, E.M. Tuzcu, C. Apperson-Hansen Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial Circulation 113 2006 2826 2834
17. S.E. Nissen, S.J. Nicholls, I. Sipahi Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
18. C.P. Cannon, E. Braunwald, C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
19. P.M. Ridker, C.P. Cannon, D. Morrow C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
20. P.M. Ridker, E. Danielson, F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
21. A. Schmermund, S. Achenbach, T. Budde Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial Circulation 113 2006 427 437
22. R. Corti, Z.A. Fayad, V. Fuster Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging Circulation 104 2001 249 252
23. X.Q. Zhao, C. Yuan, T.S. Hatsukami Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study Arterioscler Thromb Vasc Biol 21 2001 1623 1629
24. M. Abe, M. Matsuda, H. Kobayashi Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages Arterioscler Thromb Vasc Biol 28 2008 871 877
25. T. Khan, M.P. Hamilton, D.I. Mundy, S.C. Chua, P.E. Scherer Impact of simvastatin on adipose tissue: pleiotropic effects in vivo Endocrinology 150 2009 5262 5272
26. Y.W. Wu, H.L. Kao, C.L. Huang The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers Eur J Nucl Med Mol Imaging 39 2012 399 407
27. H. Takase, Y. Dohi, T. Okado, T. Hashimoto, Y. Goto, G. Kimura Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study Eur J Clin Invest 42 2012 1287 1294
28. H.C. Stary, D.H. Blankenhorn, A.B. Chandler A definition of the intima of human arteries and of its atherosclerosis-prone regions A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 85 1992 391 405
29. V. Subbotin Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis Theor Biol Med Model 9 2012 11
30. P.R. Moreno, K.-R. Purushothaman, M. Sirol, A.P. Levy, V. Fuster Neovascularization in human atherosclerosis Circulation 113 2006 2245 2252
31. L. Dong, W.S. Kerwin, H. Chen Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum-evaluation by using dynamic contrast-enhanced MR imaging Radiology 260 2011 224 231
32. J.H. Nichols, B. Samy, K. Nasir Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study J Cardiovasc Comput Tomogr 2 2008 288 295
33. M. Janik, G. Hartlage, N. Alexopoulos Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies J Nucl Cardiol 17 2010 841 847
34. P.M. Gorter, A.M. de Vos, Y. van der Graaf Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography Am J Cardiol 102 2008 380 385
35. A. Yerramasu, D. Dey, S. Venuraju Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis Atherosclerosis 220 2012 223 230
36. K.K. Ray, C.P. Cannon, C.H. McCabe Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol 46 2005 1405 1410